David Sunseri, Ph.D, was appointed CEO of PMI BioPharma Solutions in August 2018. As CEO, David is responsible for leading the overall strategic direction of the company. He previously was the Senior Vice President, Pharmaceutical Development and Chief Business Development Officer at PMI Bio. In these roles, he was responsible for leading development programs and developing new business opportunities to drive growth for PMI Bio.
Prior to PMI Bio, David spent almost four years at Berg, LLC, in positions of increasing responsibility leading all aspects of CMC during this time. Most recently, he was the Vice President, Product Development responsible for clinical trial manufacturing, engineering operations, supply chain, and formulations. David spent approximately 10 years with Schering-Plough and Merck in small molecule inhalation and parenteral development and commercial manufacturing of inhalation and medical device products.
David received his bachelor’s degree in Chemistry from the University of North Alabama and Ph.D. in Analytical Chemistry, specializing in Chromatography, from Florida State University under the direction of John G. Dorsey.
David serves on the University of North Alabama Foundation Board of Directors. He is the Treasurer of the Foundation, Chair of the Budget, Finance, and Audit Committee, and member of the Executive Committee. He also serves on the University of North Alabama’s College of Arts and Sciences Advisory Council.